title: MICROBIOLOGY. Phage therapy redux--What is to be done?
authors.affiliation: Center for Phage Technology, Texas A&M University, College Station, TX 77843, USA. Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA. ryland@tamu.edu jason.gill@tamu.edu.
authors.forename: Ry
authors.initials: R
authors.lastname: Young
authors.affiliation: Center for Phage Technology, Texas A&M University, College Station, TX 77843, USA. Department of Animal Science, Texas A&M University, College Station, TX 77843, USA. ryland@tamu.edu jason.gill@tamu.edu.
authors.forename: Jason J
authors.initials: JJ
authors.lastname: Gill
mesh_terms: D001430:Bacteriocins; D001691:Biological Therapy / Q000379:methods*; D002056:Burns / Q000382:microbiology / Q000628:therapy; D017899:Caudovirales; D024881:Drug Resistance, Bacterial; D016908:Gram-Positive Bacterial Infections / Q000628:therapy*; D006801:Humans
chemical_list: D001430:Bacteriocins